Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
66 participants
INTERVENTIONAL
2008-01-31
2011-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Minimal and Brief Treatments for Pathological Gamblers
NCT00203645
Gambling and Brief Interventions
NCT00183599
Computer-based Self-Help Program for People With Gambling Problems
NCT03372226
Brief Therapies for Problem Gambling Substance Abusers
NCT00685048
Optimization of the Self-exclusion Procedure
NCT04802226
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Following 2 sessions of MET intervention received by all patients, patients in Condition 1 receive no further intervention.
Motivational Enhancement Therapy (MET)
MET is a client-centered, directive form of therapy designed to enhance clients' intrinsic motivation to change.
2
Patients in Condition 2 will receive 8 sessions of the CBT (Cognitive Behavioral Therapy) intervention.
Motivational Enhancement Therapy (MET)
MET is a client-centered, directive form of therapy designed to enhance clients' intrinsic motivation to change.
3
Patients in Condition 3 will receive 8 sessions of CBT plus aftercare treatment.
Motivational Enhancement Therapy (MET)
MET is a client-centered, directive form of therapy designed to enhance clients' intrinsic motivation to change.
Cognitive-Behavioral Therapy (CBT)
In CBT, clients learn to modify their thoughts as well as their behaviors by increasing awareness of the relationship between thoughts, emotions, and actions.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Motivational Enhancement Therapy (MET)
MET is a client-centered, directive form of therapy designed to enhance clients' intrinsic motivation to change.
Cognitive-Behavioral Therapy (CBT)
In CBT, clients learn to modify their thoughts as well as their behaviors by increasing awareness of the relationship between thoughts, emotions, and actions.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* \>2 gambling episodes in past 60 days
* spent \>$100 wagering in the past 60 days
* willingness to accept random assignment after the brief intervention.
Exclusion Criteria
* uncontrolled psychiatric conditions (e.g., active suicidal intention, psychosis, bipolar disorder)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Drug Abuse (NIDA)
NIH
UConn Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nancy M Petry, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
UConn Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Connecticut Health Center
Farmington, Connecticut, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
07-259
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.